Last year I connected GLP-1 medications to the rise of perfume obsession. I still believe I was right, but I was not seeing the full picture.
When I wrote How GLP-1 Medications Sparked a New Era of Perfume Obsession, I was tracing the first visible change. People on these medications were telling me their sense of smell felt different. Perfumes, especially gourmands, didn’t just smell good, they smelled edible, indulgent, almost like food. Vanilla felt like dessert. Rose felt like sugar.
The theory was straightforward. If food was no longer giving the same joy, scent could fill that space. A bottle of perfume, especially one with an edible edge, became a stand-in for a slice of cake or a favorite cocktail.
I still believe that was true, and still is. But it is not the whole story.
The New Layer
After a year of watching launches, tracking sellouts, and listening to collectors describe their habits, I see something else happening. It is bigger than just what people want to smell. It is about how they go after it.
GLP-1 drugs like Ozempic, Wegovy, and Mounjaro work by suppressing appetite. They also change how the brain’s reward system works. Dopamine, the chemical that drives motivation and satisfaction, is closely tied to eating. When food stops delivering that hit, the brain looks elsewhere.
GLP-1s turn down the urge to consume, but the urge to pursue and acquire can still run hot. In some people, it intensifies. The brain looks for a new dopamine source, and collecting becomes the perfect fit.
This is not to say that every perfume collector is on GLP-1 medication. Collecting existed long before this trend. But GLP-1 users form a fast-growing, highly engaged segment of consumers, and their behavior may be quietly reshaping the market in ways the industry has not fully recognized.
Why Perfume
Perfume delivers dopamine in three stages.
- The Hunt: On Reddit and Fragrantica, threads run for pages as members track sightings and exchange intel. Gray market sites are refreshed on repeat, hoping for a sudden drop at a deep discount. YouTube reviews and TikToks from fragrance influencers are replayed like clues in an investigation, each one keeping the anticipation alive.
- The Acquisition: Once the decision is made, it is done. This is where blind buying often happens. Before I began tracking the fragrance industry, I had never even heard the term. Launch day means alarms set, browsers preloaded, and payment details ready to go. In fragrance chat groups, there is a competitive edge as screenshots of order confirmations are posted like trophies. Those who miss out start planning the next attempt before the disappointment even settles.
- The Arrival: Boxes are opened slowly, packaging inspected, bottles examined in the hand. Some people share the moment publicly, others keep it private. The first spray matters, but for many the real satisfaction comes from the act of possession itself. Often, the focus shifts quickly, sometimes immediately, to the next hunt.
Most women own two to five perfumes. In fragrance forums today, it is not unusual to see collections of 300 or more. Spare rooms are converted into bottle archives. Shelves sag under the weight of glass.
One collector told an online group, “I went from two bottles to fifty in less than a year. If I do not have something in the mail, I feel low.” Another admitted, “It is not about the smell anymore. I am addicted to the search and the package arriving.”
Patterns Emerging
The night Kayali Wedding Silk Santal launched, Sephora’s website crashed before midnight. Shoppers had been refreshing for hours. Carts froze, payment pages failed, and within minutes the fragrance was gone.
Valentino Donna Born in Roma Ivory was different but equally telling. It launched as a Sephora and Valentino.com exclusive. No department stores. No other retailers. It sold out on Sephora the same day, then quickly disappeared from Valentino’s site. Marketed as a limited edition, it was not truly rare. The scarcity was in the rollout, not the production.
Then came Commodity Milk Orchid. It sold out in eight minutes on Sephora. Eight minutes. In online fragrance groups, people compared checkout times as if they were race results. By the time most people heard about it, it was already history.
The industry may not yet understand the psychology driving this pace of buying, but their launch playbooks, exclusivity, staggered releases, engineered scarcity, are providing exactly what the anticipation-driven consumer wants.
The Scale
This is not a niche phenomenon. In the United States, nearly 12 percent of adults have taken a GLP-1 medication. Among women aged 50 to 64, it is one in five. Globally, analysts project 40 million users by 2029, with nearly half in the U.S.
These are connected, visually fluent consumers. Social media amplifies their behavior. A launch does not just sell a product; it generates haul videos, shelf tours, and unboxings that feed the algorithm. Every post fuels the next buy. The feedback loop is constant.
Scarcity by Design
Brands have learned to design launches around this behavior, whether or not they understand the role GLP-1 medications may be playing in it.
Kayali’s midnight crash was the result of a capped, timed drop. Valentino’s rollout withheld the fragrance from department stores to create urgency. Commodity’s eight-minute sellout was possible because launch inventory was intentionally small.
The fear of missing out is no longer a byproduct. It is part of the product.
But Wait, It’s Not Just Perfume
Perfume may be the clearest example, but the same pattern is playing out in other luxury and collectible markets, watches, handbags, sneakers, and high-end streetwear.
The $27-billion pre-owned mechanical watch market is growing by up to 12 percent annually. Demand for rare and discontinued models is rising, and this is no longer driven only by seasoned collectors. A new wave of buyers, including younger men in their twenties and thirties, is entering the market. Some are first-time luxury buyers, drawn in by the thrill of the hunt more than the need for the product itself.
The shift in demographics mirrors the rapid adoption of GLP-1 medications. Prescriptions among younger consumers, including men, have grown sharply in the past three years. This group is highly active online, fluent in the language of drops and exclusives, and accustomed to chasing scarcity in other consumer categories like sneakers and gaming consoles.
The overlap is striking. Whether it is a fragrance, a limited-edition watch, or a rare sneaker, the mechanics are the same: the hunt, the acquisition, the display.
The Perfect Consumer
Luxury brands are not asking why someone needs 300 perfumes or five versions of the same watch. These buyers shop often, share their purchases publicly, and create free advertising with every post.
GLP-1 medications may be creating the perfect consumer. Appetite for food may fade, but appetite for the next package is thriving.
A year ago, I thought the GLP-1 perfume obsession was about taste replacement. I still believe that was part of it. But now I see the larger truth. This is not just about scent. It is about a rewired reward system, a surge of acquisition, and a collecting economy where the pursuit itself has become the luxury.
If you are seeing this shift in your own circles or in yourself, I want to hear about it. Share your stories, your collections, and your theories. The more we understand how GLP-1 medications are shaping desire, the better we can see where the collecting economy is headed next.
Leave a Reply